Connecticut Innovations
Government fundNew Haven · Pre-Seed–Growth · 8 people tracked
Investment thesis
Connecticut Innovations invests capital and strategic support in early stage and growth companies based in Connecticut, aiming to strengthen the state as an innovation hub. It operates several dedicated funds: a $100M ClimateTech Fund for early stage and growth climate companies, a $50M AI/Q Fund targeting scalable commercial ventures at the intersection of artificial intelligence, quantum computing, and deep tech, a $50M Future Fund backing new and diverse ideas, people and industries, and a $200M evergreen Connecticut Bioscience Innovation Fund focused on bioscience. The organization emphasizes flexible financing across every stage of business development and hands-on operational support from experienced business partners.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directoriesWhat they invest in
from 202 of 252 portfolio companiesBiotech ×55AI & Machine Learning ×48Healthtech ×47Medical Devices ×39SaaS ×30Enterprise Software ×29Consumer ×21Digital Health ×21
HQs:United States×99Israel×3Canada×1United Kingdom×1India×1Netherlands×1
Investments · 252 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 32023 · 42022 · 42021 · 22020 · 12019 · 12018 · 32017 · 22016 · 526 dated
Arvinas is a clinical-stage biopharmaceutical company developing PROTAC protein degrader therapies for oncology and neurology.
BiotechNew Haven, US
Andrew Levin(Director)Sean Cassidy(Executive Officer)Jonathan Soderstrom(Director)Brad Margus(Director)Manuel Litchman(Executive Officer, Director)Kush Parmar(Director)
New Haven, US
Tantalus provides a Grid Modernization Platform that enables utilities to manage electricity distribution infrastructure through data interoperability across devices and systems, including legacy equipment and distributed energy resources.
Data & InfrastructureEnergyIoTBurnaby
John McEwen(Director)Dermot O'Leary(Executive Officer)Francis Harvey(Director)Peter Londa(Executive Officer, Director)
BoardAllen Beasley(Director)
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing therapeutics for pattern hair loss in men and women.
BiotechHealthtechWest Hartford, US
John W. Childs(Director)Reid Waldman(Executive Officer, Director)Jane Grant-Kels(Director)Vladimir Coric(Director)Timothy Durso(Executive Officer, Director)
Aeromics is a clinical-stage biopharmaceutical company developing AER-271, an aquaporin-4 inhibitor to prevent cerebral edema (brain swelling) in severe acute ischemic stroke patients.
BiotechMedical DevicesNew Haven, US
Dr. Pelletier(Founder)Dr. Boron(Founder)Frederick Jones(Director)Paul McGuirk(Executive Officer)Walter Boron(Executive Officer, Director)George Farr(Executive Officer)
NourishedRx provides a data-driven nutrition care platform that connects health plans, providers, and government agencies with clinically guided meal plans and health coaching to address chronic diseases and nutrition insecurity.
Digital HealthFoodTechHealthtech
OmniCyte develops targeted immunotherapy treatments for cancer patients using a proprietary immuno-oncology platform technology, with initial focus on ovarian cancer and small cell lung cancer.
BiotechMedical DevicesNew York, US
Yuma powers decentralized AI projects built on the Bittensor network, connecting entrepreneurs and developers with resources to build and launch subnets.
AI & Machine LearningCrypto & Web3Deep Tech
Greg SchveyJeff Schvey
Travel & HospitalityNew York, US
Steven Elkes(Executive Officer)Michael Keriakos(Executive Officer, Director, Promoter)William Peabody(Director)
Board seatMatthew McCooe· per SEC Form D · $3.3M raise · filed Aug 2021
AbbraTech develops a platform technology for discovering and validating antibody therapies targeting disease.
BiotechBranford, US
Aceiss detects unauthorized employee access to company systems and monitors user privileges across applications to prevent cyber attacks.
CybersecurityDeveloper ToolsEnterprise Software
Achillion is a biopharmaceutical company focused on research and development of treatments for rare diseases, investigating new targets, modalities, and technologies.
BiotechHealthtech
ActiveCampaign is a marketing automation platform that uses AI to manage email, SMS, and WhatsApp campaigns across integrated marketing channels.
AI & Machine LearningMarketing TechSaaS
Advanced Telepsych provides mental health care via telepsychiatry, including support for children and adolescents.
Digital HealthMental HealthLongmeadow, US
Andrew Zaback(Executive Officer)
Alexion is a biopharmaceutical company focused on researching and developing treatments for rare diseases, investigating new targets, modalities and technologies to address patient needs globally.
BiotechBoston, US
Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Paul Fonteyne(Co-Founder)Stephen Strittmatter(Scientific Founder)Stephen Bloch(CEO, Co-Founder)Timothy Siegert(COO, Co-Founder)Jennifer Gabler(Executive Officer)
BoardRobert A. Bettigole(Director)
BiotechNew Haven, US
Ranjit Bindra(Director)Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Kevin L. Rakin(Executive Officer, Director)Stanley Choy(Executive Officer)
BoardColleen Cuffaro(Director)
ACC Premiere is an outsourced contact center provider offering omnichannel customer support that combines AI-powered automation with live agents, including technical support, sales, customer service, and crisis and recall management.
AI & Machine LearningEnterprise SoftwareSaaS
Apriligen develops autologous gene therapies for pediatric monogenic diseases, starting with Diamond Blackfan Anemia Syndrome.
BiotechHealthtechMedical Devices
Arccos is an AI-powered golf performance analytics platform that tracks player shots and game metrics across 1.5 billion rounds to provide personalized insights and strategy recommendations.
AI & Machine LearningHardwareSports Tech
Asarasi produces sparkling water made from maple tree sap, sourced sustainably from living trees as a renewable alternative to groundwater-based bottled water.
CleantechConsumerFoodTech
Athletic Brewing produces craft non-alcoholic beer in multiple styles including IPAs, pale ales, radlers, and sours for consumers seeking flavorful beverages without alcohol.
ConsumerFoodTechMilford, US
William Shufelt(Manager, Chief Executive Officer of the Issuer)John Walker(Director)
BoardAlyssa Ferenz(Director)Harry Schwefel(Director)Timothy Barakett(Director)Harrison DiGia(Director)
AtlasXomics develops spatial epigenomics tools, spanning chip fabrication, hardware, and bioinformatics, for researchers studying areas such as cancer and systems biology.
BiotechDeep TechHealthtechNew Haven, US
Gregory Ho(Director)Richard Andersson(Director)Kenneth Wang(Investor and entrepreneur (board member))
BiotechFarmington, US
Patrick O'Neill(Director)Paul Higham(Director)Terrence Coffey(Director)Maxim Budyansky(Executive Officer, Director)Neil Shah(Executive Officer, Director)
BEKhealth provides AI-powered clinical intelligence software that extracts data from electronic health records to enable faster clinical trial recruitment and real-world evidence generation.
AI & Machine LearningDigital HealthHealthtechBranford, US
Joshua Ransom(Executive Officer)David Levin(Executive Officer, Director)inJason Baumgartner(Executive Officer, Director)
BoardBobby Bahram(Director)Jeanne Hecht(Director)John Crumpler(Director)
Better Rhodes is a marketplace for non-alcoholic beverages, offering premium alcohol-free wines and craft NA beers through monthly subscription clubs.
ConsumerE-commerceMarketplacesMadison, US
Daniel Stiller(Executive Officer, Director)Christopher Becker(Director)
Biohaven is a biopharmaceutical company focused on discovering and developing treatments in immunology, obesity, neuroscience, and oncology, including approved migraine medications.
BiotechHealthtechMedical Devices
BiologicsMD develops recombinant fusion proteins targeting parathyroid hormone receptors for hair loss, bone disorders, and oncology treatments.
BiotechDeep TechMedical DevicesFayetteville, US
Ramsay Ball(Director)Robyn Goforth(Executive Officer)Calvin Goforth(Director, Promoter)Rob Gensure(Executive Officer)J. David Owens(Executive Officer, Director)Lynn Kirkpatrick(Director)
BioWave develops a wearable neurostimulation device that delivers high-frequency electrical stimulation directly to nerves to block pain signals, marketed as a treatment for chronic pain conditions without requiring continuous use.
HealthtechMedical DevicesNorwalk, US
Robert Adler(President)Bradford Siff(CEO and Secretary)Lance Lundberg(Director)L. Charles (Duke) Meythaler(Director)Bruce Lev(Director)David Kratovil(Chief Operating Officer)
Bloom provides credit data infrastructure and underwriting technology for financial institutions, fintechs, and credit unions to make lending decisions and build credit.
Data & InfrastructureFintech
Bright Feeds develops technology to transform unwanted food into animal feed, helping food companies meet sustainability goals while reducing waste.
Circular EconomyFoodTech
Budderfly provides energy management services for businesses, upgrading operational infrastructure with energy-efficient equipment and monitoring systems to reduce energy consumption by up to 30%, operating on a performance-based model where the company is paid from the savings generated.
CleantechEnterprise SoftwareIoT
Al Subbloie(Founder and CEO)
C2 Ventures is a venture capital firm that invests in AI-powered software solutions for industries with high-risk, repetitive, or hazardous work.
AI & Machine LearningEnterprise SoftwareSaaS
Cambium develops technology and marketplace infrastructure for the wood industry, connecting buyers and sellers while offering sustainably sourced wood products made from waste material.
B2B MarketplacesClimate TechLogistics & Supply ChainNew MaterialsCalifornia, US
Theo Hooker(Executive Officer, Director)Marisa Repka(Executive Officer, Director)Ben Christensen(Founder & CEO)
Cape Haven Bio is a venture creation firm focused on translating early-stage academic discoveries into commercially viable biotech companies developing therapeutics.
BiotechDeep TechNew Haven, US
Carbon Built produces ultra-low carbon concrete masonry and hardscapes for construction projects by substituting conventional cement with a proprietary upcycled binder, achieving up to 70% reduction in carbon footprint.
CleantechClimate TechConstruction TechTorrance, US
Gaurav Sant(Director)Rahul Shendure(Executive Officer, Director)
BoardEdward Muller(Executive Officer, Director)Neil Renninger(Director)
CaroGen develops immunotherapies for cancer treatment, including the CARG-2020 platform for ovarian and colorectal cancer, and is partnering with the NIH on a universal influenza vaccine.
BiotechHealthtechFarmington, US
CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications.
AI & Machine LearningBiotechMedical Devices
CiDRA provides SMARThatch, a real-time measurement system for ready-mix concrete trucks that monitors air content, volume, temperature, and other parameters via acoustic technology.
Advanced ManufacturingConstruction TechIoT
CiDRA Minerals Processing develops mineral separation and processing technologies for mining operations, including SonarTrac and CycloneTrac solutions that improve mill grinding efficiency and flowsheet design.
AgTech
Browse all 252 investments with full details →
▶52 more tracked companies
Revalia Bio, Inc.RevMedicaRho BioRNA ConnectRoundtrip EV Solutions Inc.Savant Systems, Inc.Scalable RoboticsSedentary Medical Solutions LLCShelf Inc.SilverSkySimcha TherapeuticsSirona-Medical Technologies, Inc.Skyview VenturesSlideSloohSmartequipSolais Lighting, Inc.Sonata ScientificSource DefenseSpiceSquare 9 SoftworksStanding Stone, Inc.StemifyStoryhubStovaSurreal FlowerSustainable Real Estate Solutions, Inc.Talam BiotechTamarack GlobalTastes NaturalThayerMahanThe Real FeelThetis Pharmaceuticals LLCTidal River FundTorigen PharmaceuticalsTrashieUpSwing HealthValera HealthValisureVesey VenturesVistaraViziumVoiceittVortexWaldoWave Drowning Prevention SystemsWellinksWheelhouse GroupWRM SoftwareZenapse, Inc. SaaS AIZoneflow Reactor TechnologiesZorus
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 5
IPOs and acquisitions across the tracked portfolioArvinas Holding Co. LLCNASDAQ: ARVNRallybio, LLCNASDAQ: RLYBTantalus SystemsOTC: TGMPFVeradermicsNYSE: MANEMongooseacq. by IfByPhone
Portfolio news
latest coverage across their companiesVeradermics · tipranks.com · Aug 3, 2026
Rejuvenate Bio · intelligence360.news · Jul 30, 2026
Slide · foreignpolicyjournal.com · Jul 18, 2026
Bullish · marketbeat.com · Jul 18, 2026
Classiq · funderintel.com · Jul 16, 2026
Tantalus Systems · simplywall.st · Jul 16, 2026
Empirium · finance.yahoo.com · Jul 15, 2026
Luxy · archynewsy.com · Jul 15, 2026
Frequently asked questions
- What stage does Connecticut Innovations invest at?
- Connecticut Innovations invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
- What is Connecticut Innovations's typical check size?
- Connecticut Innovations typically writes checks of $500K – $2M.
- What sectors does Connecticut Innovations focus on?
- Connecticut Innovations focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Consumer, Deep Tech, Enterprise Software, IoT, Quantum Computing, Sector Agnostic.
- Where is Connecticut Innovations located?
- Connecticut Innovations is headquartered in New Haven, US.
Co-investors · 19
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.
Early-stage venture capital firm focused on digital health innovations including digital diagnostics, digital therapeutics, and tech-enabled services. Based in Boston and Philadelphia with deep clinical expertise and experience building and scaling healthcare ventures.
Commerce Ventures is a venture capital firm that partners with entrepreneurs building platforms for the future of retail and financial services.
Crosscut Ventures is an early-stage venture capital firm that has backed founders across industries and geographies since 2008.
Primetime Partners is an early-stage venture capital fund that incubates and invests in companies transforming the quality of living for older adults, focused on the longevity economy.
National Grid Partners is the venture capital unit of National Grid plc, a major investor-owned energy utility company. The firm invests in innovative energy-related technologies and business models.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Sony Innovation Fund is split into several separate funds instead of one, including an early-stage fund run directly by Sony, a growth-stage fund with Daiwa, a climate-focused fund, an Africa entertainment fund, and later-stage funds through Sony Ventures, with investment decisions made by a committee that includes corporate executives and business division heads; it doesn't require startups to work with Sony, though about 40% end up collaborating with the company in some way across areas like gaming, semiconductors, electronics, music, film, and finance. The fund has backed unusual, frontier-type companies like an odor digitization startup, a sampling-rights marketplace, an AR display company, and a heart-failure regenerative medicine company, and its leaders describe the work as end-to-end business incubation covering sourcing, diligence, execution, value enhancement, monitoring, and exit rather than just providing capital.
IA Capital Group is a venture capital firm founded in 2000 that invests in financial services and insurance technology companies, partnering with experienced management teams. It operates a strategic venture capital platform used by numerous insurers.
Healthy Ventures is an early-stage venture investor focused on health tech, backing founders reimagining healthcare infrastructure.
Convective Capital is an investment firm focused on companies building systems that make the world disaster-proof, spanning hardware, software and financial services that manage physical-world risk. It operates Updraft, a 10,000+ person resilience network connecting utilities, agencies, insurers and emergency services.
Jerusalem Venture Partners (JVP) is a venture capital firm investing across early and growth stages, building international category-leading technology companies out of Israel and New York.
▶7 more co-investors
Digitalis VenturesAlpine MeridianStarframeFlashpoint Venture CapitalLeta CapitalSway VenturesBlackwood Healthcare Breakthroughs
Firms observed investing alongside Connecticut Innovations, from public investor directories. Shared companies are the overlap with Connecticut Innovations's recorded portfolio.
Similar investors
BDC (Business Development Bank of Canada) publishes research and analysis on issues affecting small and medium-sized businesses in Canada, including venture capital landscape reports, financing outlook surveys, and sector outlooks.
Alumni Ventures (AV) is a venture firm that gives accredited individual investors access to professionally managed, diversified venture portfolios by co-investing alongside leading lead VC firms. It offers annual funds, syndicate deal-by-deal investing, and various investor clubs.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Oxford Investment Consultants (OIC) backs founders commercialising scientific research from Oxford University and other leading UK research institutions, managing the Oxford Technology and Innovations EIS Fund (OTIF).


















